Not all patients with CLL involve therapy. Despite all new advancements, the iwCLL still endorses watchful observation for sufferers with asymptomatic disease.86 This suggestion is predicated on at the least two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). ddbola selalu memberikan promosi dan https://marcellex975wfo3.blogrenanda.com/profile